Discover what's new.

Access the latest news, business developments, company updates, industry trends, events and more.

| By Kelley Gipson

Fierce Biotech profiles DotLab

DotLab seeks to make the diagnosis of endometriosis as simple as a blood test. The company came out of stealth last year with an early...

| By Kelley Gipson

Pfizer, BioNTech team up against COVID-19

Pfizer has teamed up with BioNTech to co-develop and distribute a mRNA vaccine against COVID-19 outside of China. The partners plan to use multiple R&D...

| By Kelley Gipson

Arvinas announces policy for working remotely

Arvinas recently announced implementation of a remote work policy intended to minimize the potential of exposure to COVID-19 while maintaining lab-based operations as long as...

| By Kelley Gipson

Pfizer outlines 5-point plan to battle COVID-19

Pfizer issued a five-point plan calling on the biopharmaceutical industry to join the company in committing to unprecedented collaboration to combat COVID-19. more

| By Kelley Gipson

BioCT open for business remotely

As of March 16, in accordance with guidelines issued by Governor Lamont and the recommendations of the Centers for Disease Control (CDC), BioCT staff are...

| By Kelley Gipson

BIO opens Coronavirus Business Resource Center

Dear BioCT Community, As many companies work to develop diagnostics, vaccines and treatments to address the global COVID-19 outbreak, we want to help all of...

| By Kelley Gipson

CaroGen and Yale start work on COVID-19 vaccine

Farmington-based CaroGen and scientists from Yale have begun work on a vaccine targeting the coronavirus responsible for the ongoing global outbreak of COVID-19 disease. The...

| By Kelley Gipson

newhavenbiz recognizes 2020 ‘Power 50’

The magazine newhavenbiz recently recognized The Power 50 Class of 2020. I am so proud to be part of the evolution of the bio industry...

| By Kelley Gipson

UConn researcher gets NIH funding re tumor growth

A researcher at the UConn School of Dental Medicine recently received a $2.5 million grant from the National Cancer Institute to further investigate cancer growth...

| By Kelley Gipson

Vanessa appoints Childs Corporate Controller

Vanessa Research has appointed Stephen Childs Corporate Controller, effective March 23, 2020. Childs is a graduate of Quinnipiac University and holds a graduate certificate in Accounting from the...